GRACEcast Cancer 101 Video
ASCO Lung Cancer Highlights, Part 12: Ganetespib with Second Line Chemotherapy for Advanced NSCLC (audio)
- Autor: Podcast
- Narrador: Podcast
- Editor: Podcast
- Mas informaciones
Informações:
Sinopsis
Dr. Edward Garon, David Geffen School of Medicine at UCLA, reviews impressive results from the GALAXY-1 trial of the heat shock protein inhibitor ganetespib combined with combined with second line docetaxel in advanced lung adenocarcinoma.
